Global Physician Dispensed Cosmeceutical Industry

Jan 27, 2016, 19:39 ET from ReportBuyer

LONDON, Jan. 27, 2016 /PRNewswire/ -- This report analyzes the worldwide markets for Physician Dispensed Cosmeceuticals in US$ Thousand by the following Segments: Physician Dispensed Skin Care Products, and Physician Dispensed Eyelash Products. The report provides separate comprehensive analytics for the US, Canada, Japan, Europe, Asia-Pacific, Latin America, and Rest of World. Annual estimates and forecasts are provided for the period 2014 through 2020. Also, a five-year historic analysis is provided for these markets. Market data and analytics are derived from primary and secondary research. Company profiles are primarily based on public domain information including company URLs. The report profiles 74 companies including many key and niche players such as -

Allergan Plc
Athena Cosmetics, Inc.
Biopelle, Inc.
Clinique Laboratories, LLC
iS CLINICAL

Download the full report: https://www.reportbuyer.com/product/960404/


I. INTRODUCTION, METHODOLOGY & PRODUCT DEFINITIONS

Study Reliability and Reporting Limitations I-1 Disclaimers.............. I-2 Data Interpretation & Reporting Level I-2 Quantitative Techniques & Analytics I-3 Product Definitions and Scope of Study I-3 Physician Dispensed Skin Care Products I-3 Physician Dispensed Eyelash Products I-3

II. EXECUTIVE SUMMARY

1. INDUSTRY OVERVIEW.............. II-1 Physician Dispensed Cosmeceuticals: A Prelude II-1 Current and Future Analysis..............II-2 Physician Dispensed Skin Care Products Gain Traction II-2

2. GROWTH DRIVERS AND MARKET TRENDS..............II-3 Mid-Life Crisis - A Key Growth Driver II-3 Cosmeceutical Consumers: A Highly Informed, Aesthetically- Conscious Group.............. II-3 Natural Ingredients Gain Attention II-3 What's Next in Ingredients..............II-4 Women Account for Highest Spends on Skin Care II-4 Customized Solutions for Uninsured Patients to go a Long Way II-4 Physician Dispensed Cosmeceuticals - A Potential Path to Invasive Procedures..............II-5 Post Procedure Topical Products in Demand II-5 Physician Dispensing Outsmarts Conventional Retail Brands II-5 Manufacturers Widen Customer Base II-5 Innovative Ingredients Gain Focus II-5 Anti-Aging Products: The Largest Segment in Skin Care Cosmeceuticals.............. II-6 Major Anti-Aging Ingredients of Cosmeceuticals II-7 Stem Cell Technology: The New Frontier II-8 Skin Brightening and Lightening Products - A High Growth Market II-8 Efficacy and New Product Launches Drive the Scar Repair Products Market.............. II-9 Table 1: World Recent Past, Current and Future Analysis for Physician Dispensed Scar Repair Products: Annual Sales Figures in US$ Thousand for Years 2014 through 2020 (includes corresponding Graph/Chart)..............II-10 Companies Focus on Complementary Products II-10 Possible Ban on Hydroquinone Stimulates Search for Other Pigment Control Products..............II-10

3. COMPETITION.............. II-11 Table 2: Global Leading Physician-Dispensed Topical Players (2015E): Percentage Market Share Breakdown of Revenues (includes corresponding Graph/Chart) II-11

4. AN INSIGHT INTO MARKET BARRIERS II-12 Debate Surrounding Physician Dispensing of Cosmeceuticals II-12 Ethical Perspective.............. II-12 Product Efficacy.............. II-13 Emergence of Medispas..............II-13 Patient Discretion and Requirement II-13 Challenges.............. II-14

5. DISTRIBUTION SCENARIO..............II-15 E-Commerce to Reinforce Sales of Physician Dispensed Products II-15 Social Networking - A New Marketing Tool II-15

6. AESTHETICS MARKET: A BRIEF INSIGHT II-17 A Prelude.............. II-17 Table 3: World Aesthetics Market (2015): Percentage Breakdown of Revenues by Segment (includes corresponding Graph/Chart) II-18 Historical and Recent Past Perspective II-18 Aging Population: A Weighty Demographic Driver II-19 Table 4: Ten Largest Populated Countries Worldwide (July 2013): Total Population (in Millions) by Age Group 0-14 Years, 15-44 Years, 45-64 Years, and 65+ Years for China, India, USA, Indonesia, Brazil, Pakistan, Nigeria, Bangladesh, Russia and Japan (includes corresponding Graph/Chart) II-20

Table 5: Ten Largest Populated Countries Worldwide (July 2013): Percentage Population by Age Group 0-14 Years, 15-44 Years, 45-64 Years, and 65+ Years for China, India, USA, Indonesia, Brazil, Pakistan, Nigeria, Bangladesh, Russia and Japan (includes corresponding Graph/Chart) II-21 Societal Pressure to Look Young Peps Demand for Facial Aesthetics II-21 Undesirable Side Effects: A Challenge to Reckon With II-22

7. PRODUCT OVERVIEW.............. II-23 Introduction to Cosmeceuticals II-23 Physician Dispensed Cosmeceuticals II-23 Physician Dispensed Skin Care Products II-23 Physician Dispensed Eyelash Products II-23 Skin Care Products - An Overview II-24 Moisturizers.............. II-24 Nourishers/Anti-Agers..............II-24 Facial Cleansers.............. II-24 Sun Care Products..............II-24 Skin Lightening Products..............II-25 Scar Repair Products..............II-25 An Insight into Key Ingredients..............II-25 Antioxidants.............. II-25 Hydroxy Acids (poly, beta, alpha) II-25 Lightening Agents..............II-25 Botanicals/Plant Extracts..............II-25 Proteins/Peptides..............II-25 Retinoids.............. II-26 OTC Retinoids.............. II-26 Niacinamide.............. II-26 Topical Peptides.............. II-26 N-Acetyl Glucosamine..............II-26

8. RECENT INDUSTRY ACTIVITY..............II-27 Actavis Takes Over Allergan Inc., Changes Name to Allergan Plc.. II-27 MDRejuvena Unveils New Skin Care Product Line II-27 LEIO Aesthetics Launches VisãoMD II-27 Obagi Medical Introduces CLENZIderm M.D II-27 Lautus Takes Over and Re-Introduces GlyDerm Skincare Line II-27 Athena Cosmetics Recommences Sale of RevitaLash® II-27 Valeant Acquires Solta Medical II-27 Merz Takes Over Skin Care Unit of Neocutis II-28 Valeant to Acquire Obagi..............II-28 Suneva Medical Announces Plans to Extend Distribution Partnership with Obagi Medical..............II-28 Tri-City Medical Center and Senté Enter in Distribution Agreement II-28 Senté Inks Contract with Scripps Health II-28

9. FOCUS ON SELECT GLOBAL PLAYERS..............II-29 Allergan Plc. (US)..............II-29 SkinMedica, Inc. (US)..............II-29 Athena Cosmetics, Inc. (US)..............II-30 Biopelle, Inc. (US).............. II-30 Clinique Laboratories, LLC (US)..............II-30 iS CLINICAL (US).............. II-31 Jan Marini Skin Research, Inc. (US) II-31 La Roche-Posay Laboratoire Pharmaceutique (France) II-31 Neutrogena Corp.
(US)..............II-32 Obagi Medical Products, Inc. (US) II-32 Pacific Bioscience Laboratories Inc. (US) II-32 SkinCeuticals (US)..............II-33 Solta Medical, Inc. (US)..............II-33 Stiefel Laboratories, Inc. (US)..............II-33

10. GLOBAL MARKET PERSPECTIVE..............II-34 Table 6: World Recent Past, Current and Future Analysis for Physician Dispensed Cosmeceuticals by Geographic Region - US, Canada, Japan, Europe, Asia-Pacific, Latin America and Rest of World Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2014 through 2020 (includes corresponding Graph/Chart)..............II-34

Table 7: World Historic Review for Physician Dispensed Cosmeceuticals by Geographic Region - US, Canada, Japan, Europe, Asia-Pacific, Latin America and Rest of World Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2009 through 2013 (includes corresponding Graph/Chart).............. II-35

Table 8: World 12-Year Perspective for Physician Dispensed Cosmeceuticals by Geographic Region - Percentage Breakdown of Value Sales for US, Canada, Japan, Europe, Asia-Pacific, Latin America and Rest of World Markets for Years 2009, 2015 and 2020 (includes corresponding Graph/Chart) II-36

By Product Segment..............II-37

Table 9: World Recent Past, Current and Future Analysis for Physician Dispensed Skin Care Products by Geographic Region - US, Canada, Japan, Europe, Asia-Pacific, Latin America and Rest of World Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2014 through 2020 (includes corresponding Graph/Chart)..............II-37

Table 10: World Historic Review for Physician Dispensed Skin Care Products by Geographic Region - US, Canada, Japan, Europe, Asia-Pacific, Latin America and Rest of World Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2009 through 2013 (includes corresponding Graph/Chart).............. II-38

Table 11: World 12-Year Perspective for Physician Dispensed Skin Care Products by Geographic Region - Percentage Breakdown of Value Sales for US, Canada, Japan, Europe, Asia-Pacific, Latin America and Rest of World Markets for Years 2009, 2015 and 2020 (includes corresponding Graph/Chart) II-39

Table 12: World Recent Past, Current and Future Analysis for Physician Dispensed Eyelash Products by Geographic Region - US, Canada, Japan, Europe, Asia-Pacific, Latin America and Rest of World Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2014 through 2020 (includes corresponding Graph/Chart)..............II-40

Table 13: World Historic Review for Physician Dispensed Eyelash Products by Geographic Region - US, Canada, Japan, Europe, Asia-Pacific, Latin America and Rest of World Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2009 through 2013 (includes corresponding Graph/Chart).............. II-41

Table 14: World 12-Year Perspective for Physician Dispensed Eyelash Products by Geographic Region - Percentage Breakdown of Value Sales for US, Canada, Japan, Europe, Asia-Pacific, Latin America and Rest of World Markets for Years 2009, 2015 and 2020 (includes corresponding Graph/Chart) II-42

III. MARKET

1. THE UNITED STATES.............. III-1 A.Market Analysis.............. III-1 US: The Largest Physician Dispensed Cosmeceuticals Market Globally.............. III-1 Anti-aging Cosmeceuticals and Sunscreens to Drive Growth III-1 Baby-boomers and Working Females Propel Demand for Skin Care Products.............. III-2 Table 15: The US Population Breakdown by Age Group (2014) (includes corresponding Graph/Chart) III-2 Competition.............. III-2 FDA to Ban Usage of Hydroquinone in Pigment Controlling Products.............. III-3 Hydroquinone-free Products Attract Attention III-3 Strategic Corporate Developments III-3 Select Key Players..............III-5 B.Market Analytics..............III-10 Table 16: The US Recent Past, Current and Future Analysis for Physician Dispensed Cosmeceuticals by Product Segment- Eyelash Products and Skin Care Products Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2014 through 2020 (includes corresponding Graph/Chart) III-10

Table 17: The US Historic Review for Physician Dispensed Cosmeceuticals by Product Segment - Eyelash Products and Skin Care Products Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2009 through 2013 (includes corresponding Graph/Chart) III-11

Table 18: The US 12-Year Perspective for Physician Dispensed Cosmeceuticals by Product Segment - Percentage Breakdown of Value Sales for Eyelash Products and Skin Care Products for Years 2009, 2015 and 2020 (includes corresponding Graph/Chart).............. III-12

2. CANADA.............. III-13 A.Market Analysis.............. III-13 Current and Future Analysis..............III-13 Anti-Aging Cosmeceuticals Market - A Review III-13 Strategic Corporate Development III-14 B.Market Analytics..............III-14 Table 19: Canadian Recent Past, Current and Future Analysis for Physician Dispensed Cosmeceuticals by Product Segment - Eyelash Products and Skin Care Products Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2014 through 2020 (includes corresponding Graph/Chart) III-14

Table 20: Canadian Historic Review for Physician Dispensed Cosmeceuticals by Product Segment - Eyelash Products and Skin Care Products Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2009 through 2013 (includes corresponding Graph/Chart) III-15

Table 21: Canadian 12-Year Perspective for Physician Dispensed Cosmeceuticals by Product Segment - Percentage Breakdown of Value Sales for Eyelash Products and Skin Care Products for Years 2009, 2015 and 2020 (includes corresponding Graph/Chart)..............III-16

3. JAPAN.............. III-17 A.Market Analysis.............. III-17 Measuring the Potential of Anti-Ageing Cosmeceuticals III-17 B.Market Analytics..............III-18 Table 22: Japanese Recent Past, Current and Future Analysis for Physician Dispensed Cosmeceuticals by Product Segment - Eyelash Products and Skin Care Products Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2014 through 2020 (includes corresponding Graph/Chart) III-18

Table 23: Japanese Historic Review for Physician Dispensed Cosmeceuticals by Product Segment - Eyelash Products and Skin Care Products Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2009 through 2013 (includes corresponding Graph/Chart) III-19

Table 24: Japanese 12-Year Perspective for Physician Dispensed Cosmeceuticals by Product Segment - Percentage Breakdown of Value Sales for Eyelash Products and Skin Care Products for Years 2009, 2015 and 2020 (includes corresponding Graph/Chart)..............III-20

4. EUROPE.............. III-21 A.Market Analysis.............. III-21 Current and Future Analysis..............III-21 Skin Care market in Europe..............III-21 La Roche-Posay Laboratoire Pharmaceutique - A Leading Player III-21 B.Market Analytics..............III-22 Table 25: European Recent Past, Current and Future Analysis for Physician Dispensed Cosmeceuticals by Product Segment - Eyelash Products and Skin Care Products Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2014 through 2020 (includes corresponding Graph/Chart) III-22

Table 26: European Historic Review for Physician Dispensed Cosmeceuticals by Product Segment - Eyelash Products and Skin Care Products Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2009 through 2013 (includes corresponding Graph/Chart) III-23

Table 27: European 12-Year Perspective for Physician Dispensed Cosmeceuticals by Product Segment - Percentage Breakdown of Value Sales for Eyelash Products and Skin Care Products for Years 2009, 2015 and 2020 (includes corresponding Graph/Chart)..............III-24

5. ASIA-PACIFIC.............. III-25 A.Market Analysis.............. III-25 Current and Future Analysis..............III-25 Asian Aesthetics Market..............III-25 FMCG Companies Maintain their Lead in Cosmeceuticals Segment in India.............. III-25 B.Market Analytics..............III-26 Table 28: Asia-Pacific Recent Past, Current and Future Analysis for Physician Dispensed Cosmeceuticals by Geographic Region - China, India and Rest of Asia-Pacific Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2014 through 2020 (includes corresponding Graph/Chart)..............III-26

Table 29: Asia-Pacific Historic Review for Physician Dispensed Cosmeceuticals by Geographic Region - China, India and Rest of Asia-Pacific Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2009 through 2013 (includes corresponding Graph/Chart) III-27

Table 30: Asia-Pacific Recent Past, Current and Future Analysis for Physician Dispensed Cosmeceuticals by Product Segment - Eyelash Products and Skin Care Products Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2014 through 2020 (includes corresponding Graph/Chart).............. III-28

Table 31: Asia-Pacific Historic Review for Physician Dispensed Cosmeceuticals by Product Segment - Eyelash Products and Skin Care Products Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2009 through 2013 (includes corresponding Graph/Chart) III-29

Table 32: Asia-Pacific 12-Year Perspective for Physician Dispensed Cosmeceuticals by Geographic Region - Percentage Breakdown of Value Sales for China, India and Rest of Asia-Pacific Markets for Years 2009, 2015 and 2020 (includes corresponding Graph/Chart)..............III-30

Table 33: Asia-Pacific 12-Year Perspective for Physician Dispensed Cosmeceuticals by Product Segment - Percentage Breakdown of Value Sales for Eyelash Products and Skin Care Products for Years 2009, 2015 and 2020 (includes corresponding Graph/Chart)..............III-31

5a. CHINA.............. III-32 A.Market Analysis.............. III-32 Elderly Population Spurs Growth III-32 Women - The Major Consumer Group for Anti-Aging Products III-32 B.Market Analytics..............III-33 Table 34: Chinese Recent Past, Current and Future Analysis for Physician Dispensed Cosmeceuticals by Product Segment - Eyelash Products and Skin Care Products Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2014 through 2020 (includes corresponding Graph/Chart) III-33

Table 35: Chinese Historic Review for Physician Dispensed Cosmeceuticals by Product Segment - Eyelash Products and Skin Care Products Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2009 through 2013 (includes corresponding Graph/Chart) III-34

Table 36: Chinese 12-Year Perspective for Physician Dispensed Cosmeceuticals by Product Segment - Percentage Breakdown of Value Sales for Eyelash Products and Skin Care Products for Years 2009, 2015 and 2020 (includes corresponding Graph/Chart)..............III-35

5b. INDIA.............. III-36 A.Market Analysis.............. III-36 Bright Outlook for Anti-Aging Cosmeceuticals Prescribed by Dermatologists.............. III-36 B.Market Analytics..............III-37 Table 37: Indian Recent Past, Current and Future Analysis for Physician Dispensed Cosmeceuticals by Product Segment - Eyelash Products and Skin Care Products Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2014 through 2020 (includes corresponding Graph/Chart) III-37

Table 38: Indian Historic Review for Physician Dispensed Cosmeceuticals by Product Segment - Eyelash Products and Skin Care Products Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2009 through 2013 (includes corresponding Graph/Chart) III-38

Table 39: Indian 12-Year Perspective for Physician Dispensed Cosmeceuticals by Product Segment - Percentage Breakdown of Value Sales for Eyelash Products and Skin Care Products for Years 2009, 2015 and 2020 (includes corresponding Graph/Chart).............. III-39

5c. REST OF ASIA-PACIFIC..............III-40 Market Analysis.............. III-40 Table 40: Rest of Asia-Pacific Recent Past, Current and Future Analysis for Physician Dispensed Cosmeceuticals by Product Segment - Eyelash Products and Skin Care Products Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2014 through 2020 (includes corresponding Graph/Chart).............. III-40

Table 41: Rest of Asia-Pacific Historic Review for Physician Dispensed Cosmeceuticals by Product Segment - Eyelash Products and Skin Care Products Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2009 through 2013 (includes corresponding Graph/Chart) III-41

Table 42: Rest of Asia-Pacific 12-Year Perspective for Physician Dispensed Cosmeceuticals by Product Segment - Percentage Breakdown of Value Sales for Eyelash Products and Skin Care Products for Years 2009, 2015 and 2020 (includes corresponding Graph/Chart)..............III-42

6. LATIN AMERICA.............. III-43 A.Market Analysis.............. III-43 Anti-Aging Products in Latin America: A Promising Space III-43 B.Market Analytics..............III-44 Table 43: Latin American Recent Past, Current and Future Analysis for Physician Dispensed Cosmeceuticals by Geographic Region - Brazil, Mexico and Rest of Latin America Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2014 through 2020 (includes corresponding Graph/Chart)..............III-44

Table 44: Latin American Historic Review for Physician Dispensed Cosmeceuticals by Geographic Region - Brazil, Mexico and Rest of Latin America Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2009 through 2013 (includes corresponding Graph/Chart) III-45

Table 45: Latin American Recent Past, Current and Future Analysis for Physician Dispensed Cosmeceuticals by Product Segment - Eyelash Products and Skin Care Products Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2014 through 2020 (includes corresponding Graph/Chart).............. III-46

Table 46: Latin American Historic Review for Physician Dispensed Cosmeceuticals by Product Segment - Eyelash Products and Skin Care Products Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2009 through 2013 (includes corresponding Graph/Chart) III-47

Table 47: Latin American 12-Year Perspective for Physician Dispensed Cosmeceuticals by Geographic Region - Percentage Breakdown of Value Sales for Brazil, Mexico and Rest of Latin America Markets for Years 2009, 2015 and 2020 (includes corresponding Graph/Chart) III-48

Table 48: Latin American 12-Year Perspective for Physician Dispensed Cosmeceuticals by Product Segment - Percentage Breakdown of Value Sales for Eyelash Products and Skin Care Products for Years 2009, 2015 and 2020 (includes corresponding Graph/Chart)..............III-49

6a. BRAZIL.............. III-50 A.Market Analysis.............. III-50 Anti-aging Products: A Significant Market III-50 B.Market Analytics..............III-51 Table 49: Brazilian Recent Past, Current and Future Analysis for Physician Dispensed Cosmeceuticals by Product Segment - Eyelash Products and Skin Care Products Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2014 through 2020 (includes corresponding Graph/Chart) III-51

Table 50: Brazilian Historic Review for Physician Dispensed Cosmeceuticals by Product Segment - Eyelash Products and Skin Care Products Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2009 through 2013 (includes corresponding Graph/Chart) III-52

Table 51: Brazilian 12-Year Perspective for Physician Dispensed Cosmeceuticals by Product Segment - Percentage Breakdown of Value Sales for Eyelash Products and Skin Care Products for Years 2009, 2015 and 2020 (includes corresponding Graph/Chart)..............III-53

6b. MEXICO.............. III-54 A.Market Analysis.............. III-54 Anti-aging Products to Witness Steady Growth III-54 B.Market Analytics..............III-55 Table 52: Mexican Recent Past, Current and Future Analysis for Physician Dispensed Cosmeceuticals by Product Segment - Eyelash Products and Skin Care Products Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2014 through 2020 (includes corresponding Graph/Chart) III-55

Table 53: Mexican Historic Review for Physician Dispensed Cosmeceuticals by Product Segment - Eyelash Products and Skin Care Products Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2009 through 2013 (includes corresponding Graph/Chart) III-56

Table 54: Mexican 12-Year Perspective for Physician Dispensed Cosmeceuticals by Product Segment - Percentage Breakdown of Value Sales for Eyelash Products and Skin Care Products for Years 2009, 2015 and 2020 (includes corresponding Graph/Chart)..............III-57

6c. REST OF LATIN AMERICA..............III-58 Market Analysis.............. III-58 Table 55: Rest of Latin America Recent Past, Current and Future Analysis for Physician Dispensed Cosmeceuticals by Product Segment - Eyelash Products and Skin Care Products Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2014 through 2020 (includes corresponding Graph/Chart).............. III-58

Table 56: Rest of Latin America Historic Review for Physician Dispensed Cosmeceuticals by Product Segment - Eyelash Products and Skin Care Products Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2009 through 2013 (includes corresponding Graph/Chart) III-59

Table 57: Rest of Latin America 12-Year Perspective for Physician Dispensed Cosmeceuticals by Product Segment - Percentage Breakdown of Value Sales for Eyelash Products and Skin Care Products for Years 2009, 2015 and 2020 (includes corresponding Graph/Chart)..............III-60

7. REST OF WORLD.............. III-61 Market Analysis.............. III-61 Table 58: Rest of World Recent Past, Current and Future Analysis for Physician Dispensed Cosmeceuticals by Product Segment - Eyelash Products and Skin Care Products Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2014 through 2020 (includes corresponding Graph/Chart).............. III-61

Table 59: Rest of World Historic Review for Physician Dispensed Cosmeceuticals by Product Segment - Eyelash Products and Skin Care Products Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2009 through 2013 (includes corresponding Graph/Chart) III-62

Table 60: Rest of World 12-Year Perspective for Physician Dispensed Cosmeceuticals by Product Segment - Percentage Breakdown of Value Sales for Eyelash Products and Skin Care Products for Years 2009, 2015 and 2020 (includes corresponding Graph/Chart)..............III-63

IV. COMPETITIVE LANDSCAPE

Total Companies Profiled: 74 (including Divisions/Subsidiaries - 79)

The United States (60) Canada (5) Europe (12) - France (6) - Germany (2) - The United Kingdom (2) - Rest of Europe (2) Asia-Pacific (Excluding Japan) (1) Africa (1)
Download the full report: https://www.reportbuyer.com/product/960404/


About Reportbuyer
Reportbuyer is a leading industry intelligence solution that provides all market research reports from top publishers
http://www.reportbuyer.com

For more information:
Sarah Smith
Research Advisor at Reportbuyer.com
Email: query@reportbuyer.com
Tel: +44 208 816 85 48
Website: www.reportbuyer.com

SOURCE ReportBuyer



RELATED LINKS

http://www.reportbuyer.com